Xencor Inc (XNCR):企業の財務・戦略的SWOT分析

◆英語タイトル:Xencor Inc (XNCR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14726
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥40,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥81,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥121,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xencor Inc (Xencor) is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer. The company provides pipeline products under preclinical development such as XmAb14045, for the treatment of acute myeloid leukemia; XmAb 5871, for treating IgG4-related disease, and also for the treatment of systemic lupus erythematosus; XmAb 7195. It offers treatment services which are being developed for asthma and allergic diseases; and XmAb13676, used in the treatment of B-cell malignancies. Xencor utilizes its proprietary XmAb technology platform to develop next generation antibody product candidates. The company’s works in partnership with pharmaceutical and biotechnology companies such as Morphosys, Janssen, Amgen, Novartis and others for their research and development activities. Xencor is headquartered in Monrovia, California, the US.

Xencor Inc Key Recent Developments

Feb 25,2019: Xencor reports fourth quarter and full year 2018 financial results
Feb 06,2019: Xencor and Genentech partner on novel IL-15 cytokine drugs
Nov 05,2018: Xencor reports third quarter 2018 financial results
Oct 05,2018: Xencor Announces Topline Results from Phase 2 Study of XmAb 5871 in Systemic Lupus Erythematosus and Selection of Late-Breaking Abstract for Presentation at the 2018 ACR Annual Meeting
Aug 06,2018: Xencor announces second quarter 2018 financial results

This comprehensive SWOT profile of Xencor Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Xencor Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Xencor Inc – Key Information
Xencor Inc – Overview
Xencor Inc – Key Employees
Xencor Inc – Key Employee Biographies
Xencor Inc – Key Operational Heads
Xencor Inc – Major Products and Services
Xencor Inc – History
Xencor Inc – Company Statement
Xencor Inc – Locations And Subsidiaries
Xencor Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Xencor Inc – Business Description
Xencor Inc – Corporate Strategy
Xencor Inc – SWOT Analysis
SWOT Analysis – Overview
Xencor Inc – Strengths
Xencor Inc – Weaknesses
Xencor Inc – Opportunities
Xencor Inc – Threats
Xencor Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Xencor Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Xencor Inc, Key Information
Xencor Inc, Key Ratios
Xencor Inc, Share Data
Xencor Inc, Major Products and Services
Xencor Inc, History
Xencor Inc, Key Employees
Xencor Inc, Key Employee Biographies
Xencor Inc, Key Operational Heads
Xencor Inc, Other Locations
Xencor Inc, Subsidiaries
Xencor Inc, Key Manufacturing facilities
Xencor Inc, Key Competitors
Xencor Inc, SWOT Analysis
Xencor Inc, Ratios based on current share price
Xencor Inc, Annual Ratios
Xencor Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Xencor Inc, Performance Chart
Xencor Inc, Ratio Charts

★海外企業調査レポート[Xencor Inc (XNCR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neuraltus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. Neuraltus’ focuses on macrophage which …
  • Capital Lease Aviation Limited:戦略・SWOT・企業財務分析
    Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nomura Research Institute Ltd (4307):企業の財務・戦略的SWOT分析
    Nomura Research Institute Ltd (4307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Eagle Energy Inc (EGL):石油・ガス:M&Aディール及び事業提携情報
    Summary Eagle Energy Inc (Eagle) is an oil and gas company that acquires for, develops and produces oil and gas reserves through its subsidiaries. It focuses on the acquisition and exploitation of conventional long-life hydrocarbon reserves in on-shore production basins in North America. It acquires …
  • Taageer Finance Co (TFCI):企業の財務・戦略的SWOT分析
    Taageer Finance Co (TFCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Indraprastha Gas Ltd (IGL):企業の財務・戦略的SWOT分析
    Summary Indraprastha Gas Ltd (IGL) is an oil and gas company that supplies natural gas. The company offers piped natural gas, liquefied natural gas, R-LNG and compressed natural gas for industrial and commercial usage. IGL compressed natural gas is used for transportation. The company's piped natura …
  • Carrols Restaurant Group, Inc.:企業の戦略・SWOT・財務情報
    Carrols Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrols Restaurant Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Peabody Energy Corp:企業の戦略・SWOT・財務分析
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BioNano Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioNano Genomics Inc (BioNano) is a developer of technology platform to analyze the segments of genomic DNA and other structural variations. The company's products include irys chip, saphyr, genome mapping systems and prep kits. Its saphyr offers breakthrough speed and throughput with unmatc …
  • Tangent Energy Solutions, Inc.:企業の戦略的SWOT分析
    Tangent Energy Solutions, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • OBJ Ltd (OBJ):医療機器:M&Aディール及び事業提携情報
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • CEZ Group:電力:M&Aディール及び事業提携情報
    Summary CEZ Group (CEZ), a subsidiary of CEZ AS, is an integrated electricity conglomerate company. The company produces and markets electricity. It generates, trades, and distributes power and heat. CEZ also provides coal mining services. The company offers services such as telecommunications, info …
  • Cimentos de Portugal SGPS SA:企業の戦略的SWOT分析
    Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Inivata Ltd:企業の製品パイプライン分析2018
    Summary Inivata Ltd (Inivata) is a cancer genomics company. The company offers products such as invisionfirst- lungin and visionseq. Its InVisionFirst offers advanced sequencing technology to detect single nucleotide variants copy number variants, insertions and deletions and structural variants in …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • UNIQA Osiguranje d.d.:企業の戦略・SWOT・財務情報
    UNIQA Osiguranje d.d. - Strategy, SWOT and Corporate Finance Report Summary UNIQA Osiguranje d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Renesola Ltd (SOL):電力:M&Aディール及び事業提携情報
    Summary Renesola Ltd (ReneSola) is a solar project developer and operator of energy efficient products that manufactures polysilicon, monocrystalline and multi crystalline solar wafers; and solar photovoltaic cells and modules. It also develops, builds and sells solar power projects across Europe, N …
  • CTI Engineering Co Ltd:企業の戦略・SWOT・財務情報
    CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Newfoundland and Labrador Hydro:企業の戦略的SWOT分析
    Newfoundland and Labrador Hydro - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Zoll Medical Corporation:医療機器:M&Aディール及び事業提携情報
    Summary ZOLL Medical Corporation (Zoll), a subsidiary of Asahi Kasei Corporation, is a provider of medical devices and software solutions for advance emergency care. The company designs, manufactures and markets resuscitation devices and systems used for resuscitation and acute critical care victims …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆